Targets of LDL Lowering Therapy in T2DM: Current Evidence and Recommendations – RSSDI 2025

Date: 6 November, 2025 – 9 November, 2025

Dr. Sudhir Bhandari contributed to the academic programme at RSSDI 2025 with a session focused on Targets of LDL Lowering Therapy in T2DM: Current Evidence and Recommendations.

Programme: RSSDI 2025
Academic Focus: Targets of LDL Lowering Therapy in T2DM: Current Evidence and Recommendations

Event Gallery